Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Cor (NQ: EXAS )

64.72 -0.24 (-0.37%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,264,568
Open 63.85
Bid (Size) 63.00 (1)
Ask (Size) 65.00 (4)
Prev. Close 64.96
Today's Range 63.39 - 65.54
52wk Range 43.90 - 100.77
Shares Outstanding 171,948,769
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Stocks at the Forefront of Personalized Medicine Trend
Unveiling the impact of personalized medicine stocks, transforming patient care, and propelling market growth seamlessly 
Via InvestorPlace
A Bull Market Is Coming: 1 Incredible Growth Stock to Buy Hand Over Fist Before It Soars 729%, According to Cathie Wood's Ark Invest
If the fund manager's calculations prove to be correct, Tesla shareholders could enjoy sevenfold returns over the coming four years. Is she right? 
Via The Motley Fool

Performance

YTD
+34.27%
+34.27%
1 Month
+8.30%
+8.30%
3 Month
-18.87%
-18.87%
6 Month
-30.68%
-30.68%
1 Year
+42.46%
+42.46%

More News

Read More
The 3 Best Digital Health Stocks for Personalized Medicine
Via InvestorPlace
Cathie Wood's Ark Invest Buys $12.6M Of Zoom Shares Following Positive Earnings
Via Benzinga
3 Biotech Stocks With Big-Time Breakthrough Potential
Via InvestorPlace
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Analyst Ratings for Exact Sciences
Via Benzinga
2 Revolutionary Stocks That Could Turn $1,000 Into $2,000 by 2030
Via The Motley Fool
Exact Sciences Sues Rival Geneoscopy Related To Colon Cancer Test Cologuard Patent
Via Benzinga
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
3 Stocks to Love Despite All of the Wall Street Hate
Via InvestorPlace
7 Biotech Stocks to Buy for Big-Time Gains
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Exact Sciences (EXAS) Q3 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Exact Sciences, A Cathie Wood Holding, Comes In Hot With Double-Digit Sales Growth
Via Investor's Business Daily
Nasdaq, S&P 500 Futures Slide Ahead Of Fed Decision, Economic Data: Analyst Tells Why November Could Herald 'Good News'
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Jim Cramer Wants You To 'Stay Away' From This Energy Corporation: 'I've Got So Many Other Good Oil Companies'
Via Benzinga
Cathie Wood's Ark Invest Sells $1.9M in Grayscale Bitcoin Fund, Sheds Coinbase Holdings And Shops For $1.8M Worth Of Robinhood Stock
Via Benzinga
3 Comeback Stocks to Buy Before They Soar Again in 2024
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Cathie Wood's Biggest Holdings Are Tumbling, Including Tesla
Via Investor's Business Daily
7 Winning Stocks That Will Make You an Investing Champion
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Cathie Wood’s 3 Favorite AI Stocks: October 2023
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
7 Affordable Stocks to Invest in as America’s Population Ages
Via InvestorPlace
Exact Sciences' Stock Offers A 'Good Entry Point,' This Bullish Analyst Says
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
Via Benzinga
Which Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.